Roic AI
Solutions
API Docs
MCP
Pricing
Discord
Resources
Toggle navigation menu
Company Search
⌘
K
Toggle theme
Toggle theme
Login
Sign up
South Korea Stocks
•
Health technology
•
Pharmaceuticals: major
NEX-I, Inc.
K
KRX:493410
Korea Stock Exchange
4,275.00
KRW
0.00
(0.00%)
ISIN
KR7493410005
Return %
Stock
S&P 500
1Y
- -
10.13
3Y
- -
64.51
5Y
- -
57.77
Use logarithmic scale
No data available
Financial data will appear here once available
Capital Structure
FRC
•
in mil. unless spec.
No data available
Financial data will appear here once available
Working Capital
FRC
•
in mil. unless spec.
No data available
Financial data will appear here once available
Growth Rates
FRC
•
in mil. unless spec.
No data available
Financial data will appear here once available
Quarterly Revenue
FRC
•
in mil. unless spec.
No data available
Financial data will appear here once available
Quarterly Earnings Per Share
FRC
•
in mil. unless spec.
No data available
Financial data will appear here once available
Quarterly Dividends Per Share
FRC
•
in mil. unless spec.
No data available
Financial data will appear here once available
Company Description
Company Profile API
ChatGPT
Google Sheets
CEO
Kyung-Wan Yoon
Sector
Health technology
Industry
Pharmaceuticals: major
Address
Seoul South Korea
IPO Date
Nov 12, 2026
Website
nex-i.co.kr
Similar Companies
Eli Lilly and Company (NYSE:LLY)
Johnson & Johnson (NYSE:JNJ)
Pfizer, Inc. (NYSE:PFE)
Novo Nordisk A/S (NYSE:NVO)
Divi's Laboratories Limited (NSE:DIVISLAB)
Dr. Reddy's Laboratories Ltd. (NSE:DRREDDY)
Business
Nex-I, Inc. engages in the development of drugs. It focuses on cancer immunotherapy. The company was founded on April 12, 2021 and is headquartered in Seoul, South Korea.
Summary
Financials
Ratios
Charts
Classic View
Statistics
Stock Splits
Stock Prices API
ChatGPT
Google Sheets
Toronto
London
Frankfurt
Dubai
Mumbai
Hong Kong
Seoul
Tokyo
Unlock non-US companies
Get Access
Already premium?
Sign in